𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A Phase II study of paclitaxel by 24-hour infusion and ifosfamide in anthracycline-resistant metastatic breast carcinoma

✍ Scribed by Jae H. Seo; Young M. Whang; Byung S. Kim; Chul W. Choi; Sang W. Shin; Yeul H. Kim; Jun S. Kim; Bum H. Goo

Book ID
102106542
Publisher
John Wiley and Sons
Year
2002
Tongue
English
Weight
72 KB
Volume
94
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Phase II trial combining paclitaxel with
Phase II trial combining paclitaxel with 24-hour infusion cisplatin for chemotherapy-naΓ―ve patients with locally advanced or metastatic breast carcinoma
✍ Chiun Hsu; Chiun-Sheng Huang; Tsu-Yi Chao; Yen-Shen Lu; Ching-Fang Bu; Mary M. C πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 78 KB πŸ‘ 1 views

## Abstract ## BACKGROUND Both paclitaxel and cisplatin are active as second‐line chemotherapy for patients with breast carcinoma. A synergistic cytotoxicity of these two drugs has been demonstrated in vitro. This study sought to determine the efficacy of combining these two drugs in the treatment

Phase II study of patients with metastat
Phase II study of patients with metastatic nonsmall cell carcinoma of the lung treated with paclitaxel by 3-hour infusion
✍ William J. Tester; Pamela Y. Jin; Deborah H. Reardon; Jeffrey B. Cohn; Martin H. πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 77 KB πŸ‘ 2 views

## METHODS. Twenty patients with histologically proven Stage IV NSCLC were en-Pennsylvania. rolled in this study. All were treated on an outpatient basis with standard premedication followed by paclitaxel 200 mg/m 2 infused intravenously over 3 hours. Treatments were repeated every 21 days for a